Trial Profile
The study of finding appropriate usage/dosage of peramivir on hemodialysis patient, an open-label study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 01 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan
- 09 Feb 2012 New trial record